Translational research in neurology and neuroscience 2010: multiple sclerosis.

Archives of Neurology
Olaf StüveTodd N Eagar

Abstract

Over the past 2 decades, enormous progress has been made with regard to pharmacotherapies for patients with multiple sclerosis. There is perhaps no other subspecialty in neurology in which more agents have been approved that substantially alter the clinical course of a disabling disorder. Many of the pharmaceuticals that are currently approved, in clinical trials, or in preclinical development were initially evaluated in an animal model of multiple sclerosis, experimental autoimmune encephalomyelitis. Two Food and Drug Administration-approved agents (glatiramer acetate and natalizumab) were developed using the experimental autoimmune encephalomyelitis model. This model has served clinician-scientists for many decades to enable understanding the inflammatory cascade that underlies clinical disease activity and disease surrogate markers detected in patients.

References

Jan 1, 1990·Annual Review of Immunology·S S Zamvil, L Steinman
Aug 13, 1987·The New England Journal of Medicine·M B BornsteinV Spada
Dec 29, 1972·Nature·D TeitelbaumM Sela
Aug 1, 1971·European Journal of Immunology·D TeitelbaumM Sela
May 1, 1982·Archives of Ophthalmology·H A Quigley, E M Addicks
Aug 1, 1996·Nature Genetics·G C EbersN Risch
Dec 1, 1996·Journal of Sleep Research·W D O'NeillS L Merritt
Jan 1, 1997·Cellular and Molecular Life Sciences : CMLS·D TeitelbaumM Sela
Jun 1, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·R PrettymanE Szabadi
Nov 27, 1997·The New England Journal of Medicine·R A RudickR M Ransohoff
Mar 24, 1998·IEEE Transactions on Bio-medical Engineering·W D O'NeillS L Merritt
Apr 10, 1999·Brain Research·B ZhuM S Cynader
Dec 29, 1999·Nature Medicine·D PittC S Raine
Mar 4, 2000·Journal of Neuroimmunology·J R KanwarG W Krissansen
Jun 16, 2000·Journal of Neuroimmunology·G MancardiA Uccelli
Oct 12, 2000·Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine·R BammerF Fazekas
Mar 7, 2001·Journal of the Neurological Sciences·G MancardiA Uccelli
Mar 29, 2001·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·T FukuchiM Matsumura
Oct 13, 2001·Lancet·R J Armstrong, R A Barker
Sep 12, 2002·Archives of Neurology·Stephen G Waxman
Jan 31, 2003·Annals of Neurology·Raju KapoorKenneth J Smith
Apr 12, 2003·Brain : a Journal of Neurology·Irmgard TegederJörn Lötsch

❮ Previous
Next ❯

Citations

Dec 19, 2012·Health Care Analysis : HCA : Journal of Health Philosophy and Policy·Anna Laura van der Laan, Marianne Boenink
Jun 28, 2011·CNS Drugs·Paulus S RommerUwe K Zettl
Sep 25, 2012·Journal of Neuropathology and Experimental Neurology·Mariella ErredeDaniela Virgintino
Feb 4, 2014·PloS One·Eléonore BeurelRichard S Jope
Feb 9, 2017·The Journal of Immunology : Official Journal of the American Association of Immunologists·Afsaneh Shirani, Olaf Stüve
Apr 23, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Eléonore BeurelRichard S Jope

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.